This House resolution expresses support for designating April 2026 as "Parkinson's Awareness Month." The text states that Parkinson's disease affects over 1,000,000 people in the United States, with nearly 90,000 new diagnoses each year. It calls Parkinson's the fastest-growing and the second most common neurodegenerative disease, and notes the disease is believed to come from both genetic and environmental factors though exact causes are often unknown. The resolution quotes CDC data saying Parkinson's is the 13th leading cause of death in the United States. It also cites an estimate that by 2045 the number of people with Parkinson's and related conditions will reach 1,700,000 and cost the United States $112,400,000,000, and that care partners faced $8,300,000,000 in lost earnings and productivity in 2024. The text lists common symptoms, calls for more research, education, and community support, and recognizes people in clinical trials and those who help care for and support people with Parkinson's.
The resolution expresses official support and encourages awareness, research, and community services for Parkinson's disease. It recognizes patients, care partners, researchers, volunteers, and organizations. It does not itself change benefits, create new programs, or direct funding.
No new federal spending or appropriations are authorized by this resolution. No publicly available information indicates it creates a funding stream. The resolution includes cited cost estimates: it states an estimated U.S. cost of $112,400,000,000 by 2045 and $8,300,000,000 in lost earnings and productivity for care partners in 2024.
The resolution supports designating an awareness month to increase attention to Parkinson's disease, to encourage research toward better treatments and a cure, to recognize people who take part in clinical trials, and to commend organizations, volunteers, researchers, and millions of individuals working to improve quality of life for people with Parkinson's and their families.
No publicly available information.